Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Immovilli

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Annals of Neurology|January 22, 2021
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple SclerosisMaria P Sormani, Nicola De Rossi, Irene Schiavetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 25, 2017
Definitive childlessness in women with multiple sclerosis: a multicenter studyDiana Ferraro, Anna Maria Simone, Giorgia Adani, et al.
Current Medical Research and Opinion|March 13, 2018
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistenceDiana Ferraro, Valentina Camera, Eleonora Baldi, et al.
Journal of Neurology|April 7, 2017
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG bandDiana Ferraro, Diego Franciotta, Roberta Bedin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Multiple Sclerosis and Related Disorders|May 1, 2020
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)Francesco Patti, Clara Grazia Chisari, Emanuele D'Amico, et al.
Multiple Sclerosis and Related Disorders|December 30, 2022
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH studyFrancesco Patti, Clara Grazia Chisari, Simona Toscano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Annals of Neurology|January 22, 2021
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple SclerosisMaria P Sormani, Nicola De Rossi, Irene Schiavetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 25, 2017
Definitive childlessness in women with multiple sclerosis: a multicenter studyDiana Ferraro, Anna Maria Simone, Giorgia Adani, et al.
Current Medical Research and Opinion|March 13, 2018
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistenceDiana Ferraro, Valentina Camera, Eleonora Baldi, et al.
Journal of Neurology|April 7, 2017
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG bandDiana Ferraro, Diego Franciotta, Roberta Bedin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Multiple Sclerosis and Related Disorders|May 1, 2020
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)Francesco Patti, Clara Grazia Chisari, Emanuele D'Amico, et al.
Multiple Sclerosis and Related Disorders|December 30, 2022
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH studyFrancesco Patti, Clara Grazia Chisari, Simona Toscano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Pageof 5